Complete Post-mortem Investigations in a Death Involving Clenbuterol After Long-term Abuse

• Published in: Journal of analytical toxicology 2019-09, Vol.43 (8), p.660-665
• Main Authors: Kintz, Pascal, Gheddar, Laurie, Ameline, Alice, Dumestre-Toulet, Véronique, Verschoore, Marion, Comte, Julien, Raul, Jean-Sébastien
• Format: Article
• Language: English
• Subjects: Anabolic Agents - administration & dosage; Anabolic Agents - adverse effects; Anabolic Agents - analysis; Autopsy; Clenbuterol - administration & dosage; Clenbuterol - adverse effects; Clenbuterol - analysis; Fatal Outcome; Forensic Pathology; Forensic Toxicology; Humans; Life Sciences; Male; Middle Aged; Substance-Related Disorders - diagnosis; Toxicology
• ISSN: 0146-4760; 1945-2403; 1945-2403
• DOI: 10.1093/jat/bkz058

Abstract The body of a 61-year-old man was found at his home by his wife, lying on the floor, near the bathroom, around midnight. He was known to be training for bodybuilding, using anabolic steroids. Police investigations revealed the presence of two types of tablets at home, one supposed to contain clenbuterol (0.040 mg) and the other stanozolol (10 mg). Testing the tablets revealed different dosages from what was expected, i.e., 0.073 and 11.5 mg/tablet, for clenbuterol and stanozolol, respectively. External body examination and autopsy, which was performed the next day, revealed generalized organ congestion and lack of any traumatic injury (confirmed by radiology). Cardiomegaly, with a heart weighing 692 g, was obvious. Anatomic pathology tests did not reveal evidence of malformations, but atheromatous plaque was identified in the coronaries during complete histology investigations. Femoral blood, urine, bile, gastric contents and two strands of hair (6 cm) were collected for toxicology. These specimens were submitted to standard analyses, but also to a specific LC–MS-MS method for clenbuterol and stanozolol testing. Clenbuterol was identified in all the tissues, including femoral blood (1.1 ng/mL), urine (7.2 ng/mL), bile (2.4 ng/mL), gastric content (3.2 ng/mL) and hair (23 pg/mg). Stanozolol only tested positive in hair (11 pg/mg). All other analyses were negative, including blood alcohol and drugs of abuse. The pathologists concluded to cardiac insufficiency with support of cardiomegaly, in a context involving repetitive abuse of anabolic drugs. This case indicates that more attention should be paid to clenbuterol, a drug widely used as a stimulant by people who want to lose weight, athletes and bodybuilding practitioners.